Reuters news agency reported on Friday that the government of Argentina has said it received 904,000 doses of Chinese pharmaceutical company Sinopharm's COVID-19 vaccine in its first delivery on 25 February 2021.
Reportedly, this delivery, part of a deal for one million doses of the COVID-19 vaccine, arrived on a plane of Argentina's state carrier from Beijing late in the evening.
According to Argentina's government, the remaining 96,000 remaining doses of the agreement with Sinopharm will arrive in the next few days.
The Foreign Minister of Argentina, Felipe Sola, tweeted: "Everyone is going to get their vaccine and Argentina will be able to move forward."
Reportedly, the Sinopharm COVID-19 vaccines received will add to the 1.22 million doses of Russia's Sputnik V COVID-19 vaccines Argentina has already received, as well as to the 580,000 doses of Covishield, manufactured by the Indian Serum Institute in conjunction with AstraZeneca and Oxford University.
So far, Argentina has recorded over two million cases of COVID-19, with nearly 52,000 deaths.
EpiVax introduces AI-enhanced models for immunogenicity prediction
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070